Delve into our case studies on ADC Synthesis, Development, and Characterization, where we reveal how:

• Trastuzumab-based ADCs with multiple payload linkers demonstrated specific, targeted functional activity.
• Flow cytometry and internalization assays confirmed antigen targeting and cellular uptake.
• Cytotoxicity assays revealed nanomolar IC50s only in HER2+ cell lines, confirming ADC efficacy and specific killing.

Brought to you by